Stockreport

Analysts Have Been Trimming Their Biodesix, Inc. (NASDAQ:BDSX) Price Target After Its Latest Report [Yahoo! Finance]

Biodesix, Inc.  (BDSX) 
PDF Revenue hit US$71m in line with forecasts, although the company reported a statutory loss per share of US$0.33 that was somewhat smaller than the analysts expected. This [Read more]